| Name | ethyl 2-amino-6-benzyl-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxylate |
|---|---|
| Synonyms |
Tinoridine, 10 mM in DMSO
tinoridine 2-amino-3-aethoxycbonyl-6-benzyl-4,5,6,7-tetrahydrothieno(2,3-c)pyridin Dimaten Cholecalciferol Impurity 26 2-amino-3-ethoxycbonyl-6-benzyl-4,5,6,7-tetrahydrothieno(2,3-c)pyridine Thieno[2,3-c]pyridine-3-cboxylic acid, 2-amino-4,5,6,7-tetrahydro-6-(phenylMethyl)-, ethyl ester Ethyl 2-amino-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-cboxylate Tinoridine //BP Nonflamin (free base) Thieno(2,3-c)pyridine-3-cboxylic acid, 2-amin ethyl 2-amino-6-(phenylmethyl)-5,7-dihydro-4H-thieno[5,4-c]pyridine-3-cboxylate Thieno(2,3-c)pyridine-3-cboxylic acid, 2-amino-4,5,6,7-tetrahydro-6-(phenylmethyl)-, ethyl ester (9CI) 3-c)pyridine-3-cboxylicacid,4,5,6,7-tetrahydro-2-amino-6-benzyl-thieno( 2-AMINO-3-ETHOXY-carbonyl-6-BENZYL-4,5,6,7-TETRAHYDROTHIEN 2-amino-6-(phenylmethyl)-5,7-dihydro-4H-thieno[5,4-c]pyridine-3-cboxylic acid ethyl ester 2-amino-6-(phenylmethyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-6-ium-3-cboxylic acid ethyl ester ethyl 2-amino-6-benzyl-4H 2-amino-6-benzyl-4,5,6,7-tetrahydrothieno(2,3-c)pyridine-3-cboxylicacidet 2-Amino-6-benzyl-3-(ethoxycbonyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine, Tinoridine ethyl 2-amino-6-benzyl-4H,5H,6H,7H-thieno[2,3-c]pyridine-3-cboxylate 2-Amino-6-benzyl-4,5,6,7-tetrahydro-thieno<pyridin-3-carbonsaeuereethylester 2-amino-6-(benzyl)-5,7-dihydro-4H-thieno[5,4-c]pyridine-3-cboxylic acid ethyl ester Y 3642 7H-thieno[2 y-3642 |
| Description | Tinoridine (Y-3642) is an orally active non-steroidal anti-inflammatory agent with potent antiperoxidative ability and radical scavenger activity. Tinoridine acts function by inhibiting COX enzyme, involves in hepatotoxicity inhibition. [1][2][3]. |
|---|---|
| Related Catalog | |
| In Vitro | Tinoridine (10-100 μM) exerts effect on stability of rat liver and kidney lysosomes, and liver parenchymal cells[3]. Tinoridine (1, 10, and 100 μM; 30 min) inhibits spontaneous release of acid phosphatase from liver lymomoses in vitro[3]. |
| In Vivo | Tinoridine (100 mg/kg; p.o.; single dose) inhibits CCl4 hepatotoxicity in rats, with a strong control of the CCl4-induced enzyme activities[2]. Tinoridine (100 mg/kg; i.p.; single dose) protects the stability of rat liver and kidney lysosomes in vivo[3]. Animal Model: Male Wistar rats (180-220 g)[2] Dosage: 100 mg/kg Administration: Oral gavage; single dose; 1 hour before CCl4 (i.p.; 0.25 mL/kg) treatment Result: Inhibited the CCl4-induced enzyme activities increase of serum glutamic-oxaloacetic transaminase and glutamic-pyruvic transaminase, and also rescued the liver microsomal cytochrome P-450 and glucose-6-phosphatase activities. |
| Density | 1.256 g/cm3 |
|---|---|
| Boiling Point | 493.5ºC at 760 mmHg |
| Melting Point | 112-113ºC |
| Molecular Formula | C17H20N2O2S |
| Molecular Weight | 316.41800 |
| Exact Mass | 316.12500 |
| PSA | 83.80000 |
| LogP | 3.58440 |
| Vapour Pressure | 7E-10mmHg at 25°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| HS Code | 2934999090 |
|---|
|
~92%
24237-54-5 |
| Literature: Meng, Shuangming; Jia, Zhifang; Wang, Kewei; Fan, Yueqin; Guo, Yong Synthetic Communications, 2014 , vol. 44, # 10 p. 1461 - 1465 |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |